Artelo Biosciences is a clinical stage pharmaceutical company developing potential first-in-class therapeutics targeting the endocannabinoid system
Link to: Pipeline
Pipeline
Our diverse set of programs are focused on diseases with significant unmet needs
Follow a manual added link
Investors
We are a NASDAQ-listed public company and we strive to provide value to our shareholders
Link to: Management
Leadership
We have decades of experience in biopharmaceutical development, commercialization, and research